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Supplemental Methods
Modelling Methods
The crystal structures of the dimeric OXA-10:avibactam complex with bromide, iodide, 
sodium, and carbon dioxide bound in the active site were used for QM/MM geometry 
optimization using the CP2K code1 (http://cp2k.berlios.de). Each protomer was solvated using 
the Solvate plugin from VMD using a box of dimensions (80  80  80) Å3. The systems were 
neutralized using a background NaCl solution with the Ionize plugin from VMD.2 Details of the 
systems studied are summarized in Table S3.
For QM/MM geometry optimizations, the interaction energy for the QM region was computed 
via the QuickStep module within CP2K,3, 4 with the FIST MM driver, and using a real-space 
multigrid technique for the electrostatic coupling between the QM and MM regions.5, 6 The QM 
region was treated using density functional theory (DFT) with the BLYP exchange correlation 
energy functional7, 8 employing the GTH pseudopotential of Goedecker et al.,9, 10 and double-
zeta valence plus polarization (DZVP) basis sets (optimized for BLYP) as implemented in 
CP2K. Br-, I- and Na+ ions were described using the DZVP basis sets optimized for BLYP. The 
plane wave was expanded up to a density cut-off of 300 Ry. For the MM region, the CHARMM 
27 force-field11 was used with the TIP3P water model, using the FIST module within CP2K to 
calculate the MM interaction energy. Interactions between the QM and MM regions were 
calculated using the procedure of Laino et al.6 MM and QM optimizations were performed 
separately, with the QM/MM interface described with the IMOMM link-atom method,12 where 
positions of hydrogen capping atoms were expressed as a function of the coordinates of atoms 
forming the original bond, and the forces on the link atoms were accordingly redistributed. A 
scaling factor of 1.38 was applied to relate the MM carbon–carbon distances to the QM carbon–
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hydrogen ones. Only the immediate active site was included in the QM region (Table S3); the 
rest of the protein was treated at the MM level. The QM/MM boundary was placed between the 
- and -carbons of Ser-67, Lys-70, Ser-115, and Trp-154. The total charge of the QM region in 
each system is summarized in Table S4. Geometry optimizations were performed for 5,000 
iterations. For every step, the electronic structure was explicitly quenched to a tolerance of 10-14 
hartree, and a convergence criteria of 10-3 for the RMS force and gradient was employed. The 
optimized geometries are given in Figure S14.
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Figure S1. Structures of -lactamase inhibitors used in our work and HEPES buffer. 
Chemical structures of clavulanic acid, sulbactam, tazobactam, avibactam, and 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES).
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Figure S2. Hydrolysis of avibactam by serine and metallo--lactamases. (A) Outline 
mechanism for serine -lactamase (SBL) acylation and recyclisation by avibactam, and observed 
mode of avibactam hydrolysis as observed with the Klebsiella pneumoniae carbapenemase-2 
(KPC-2) SBL.13 (B) Hydrolysis of avibactam as observed with the metallo--lactamase (MBL) 
Verona integron-encoded MBL-4 (VIM-4).14
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Figure S3. SEC-MALS characterisation of purified proteins. Size exclusion chromatography 
– multi-angle laser scattering (SEC-MALS) analyses showed the purity of purified OXA-10, 
OXA-23, and OXA-48, and the lack of aggregation. These data also suggested that all three 
enzymes were in a dimeric state (OXA-10: calculated 29.5 kDa, observed 51.2 kDa; OXA-23: 
calculated 31.0 kDa, observed 54.2 kDa; OXA-48: calculated 30.4 kDa, observed 55.2 kDa). 
Analyses were performed by Dr. David Staunton at the University of Oxford, Department of 
Biochemistry, Biophysics Facility. Chromatography was performed using a Superdex 75 
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HR10/30 column on a Shimadzu HPLC system, with a mobile phase of 50 mM sodium 
phosphate, pH 7.5. Detection used a Wyatt Dawn HELEOS-II 8-angle light scattering detector, a 
Wyatt Optilab rEX refractive index monitor, and an SPD20A UV/Vis detector.
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Figure S4. Pre-incubation of OXA enzymes with avibactam. The impact of avibactam on the 
hydrolysis rate of ampicillin by (A) OXA-10, (B) OXA-23, and (C) OXA-48 as observed by 1H-
NMR (700 MHz). Assays were either run immediately, or with a one hour pre-incubation step of 
avibactam and the OXA variant. The reactions consisted of 75 nM enzyme, either 100 M or 10 
mM avibactam, and 4 mM ampicillin in 50 mM Tris-d11, pH 7.5, 10 % D2O.
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Figure S5. Stability of avibactam to OXA catalysis. 1H-NMR spectra (700 MHz) of 400 M 
avibactam incubated at room temperature for 22 h with (A) no enzyme, (B) 10 M OXA-48, (C) 
10 M OXA-23, and (D) 10 M OXA-10 in 50 mM Tris-d11, pH 7.5, 10 % D2O with 10 mM 
NaHCO3. No detected avibactam hydrolysis was observed within limits of detection with any of 
the tested OXA -lactamases (< 5 %).
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Figure S6. Electron density maps for the active sites from OXA crystal structures. 2mFo-
DFc (contoured to 1.0 ) and mFo-DFc OMIT (contoured to 3.0 ) electron density maps 
representing views from the OXA-10 crystal structures. (A) Chain A of OXA-10 with bound 
HEPES (PDB 5MMY), (B, C) chains A and B of OXA-10 avibactam complex with bound 
bromide ions (PDB 5MNU), (D, E) chains A and B of OXA-10 avibactam complex with bound 
iodide ions (PDB 5MOZ), and (F, G) chains A and B of OXA-10 avibactam complex with bound 
CO2 and sodium, respectively (PDB 5MOX). Avibactam is labelled with Avi, water with W, and 
the carbamylated lysine (Lys-70) with KCX.
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Figure S7. Overlay of HEPES and avibactam binding conformations in OXA-10 structures. 
Stereo diagram of views of the OXA-10 crystal structure active site showing similar binding 
modes of HEPES (PDB 5MMY, chain A; yellow carbons) and the avibactam-derived complex 
(PDB 5MNY, chain A; white carbons). Features specific to the HEPES structure are labelled in 
red, and those specific to the avibactam complex are labelled in green. Note that Lys-70 is 
carbamylated in the HEPES complex, but not in the avibactam complex.
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Figure S8. Conformations of avibactam in OXA crystal structures. Views from crystal 
structures showing the observed conformations of avibactam in complex with OXA-10, 
compared with those in reported OXA-10, OXA-23, and OXA-48 avibactam complex 
structures.15, 16 Views from our structures of the OXA-10:avibactam complex with bound (A) 
bromide ions, (B) iodide ions, and (C) sodium ions and carbon dioxide. Note the iodide ions 
occupy one of two shown positions – refined occupancies of 70 % and 30 % for IA and IB, 
respectively. Note that we cannot rule out partial low level occupancies by other species in the 
assigned halide/sodium ion binding sites. Active site views from reported crystal structures15, 16 
of (D) OXA-10, (E) OXA-24, and (F, G, H, I) OXA-48 avibactam complexes. Structures with 
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carbamylated lysine residues have a red border, structures with bound carbon dioxide have a blue 
border, and structures with bound halide ions have a green border. Note that the orientation of 
N6 of avibactam (numbering in Figure 1C) is suitable for recyclisation in some structures (e.g., 
A, B, C, F, G, H, and some chains of I), while this nitrogen is rotated away from the 
carbamoylated serine residue in others (e.g., D, E, and some chains of I).
S15
Figure S9. OXA avibactam complexes with bound carbon dioxide. Active site views from 
crystal structures of (A) OXA-10 (PDB 5MOX, chain A), (B) OXA-24 (PDB 4WM9, chain A), 
(C, D, E) OXA-48 (PDB 4WMC, chains A, C, and F, respectively) avibactam complexes.16
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Figure S10. Multiple binding sites of halide ions to OXA-enzymes. Overall views from 
crystal structures of the OXA-10:avibactam complexes described herein with bound (A) bromide 
ions (PDB 5MNU), and (B) iodide ions (PDB 5MOZ). Overall views of the reported crystal 
structures of (C) V117T OXA-10 with bound chloride ions (PDB 2WGV),17 and (D) OXA-163 
with bound iodide ions (PDB 4S2M).18 Selected active site residues (Ser-67, Lys-70, Trp-154; 
OXA-10 numbering) and avibactam are in yellow. Note the halide ions can bind at more than 
one position in the active site and at sites away from the active site, and that we cannot rule out 
the presence of ions at relatively low occupancy levels at the assigned ion binding sites.
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Figure S11. OXA active site halide binding sites. Active site views from the OXA-10 crystal 
structures described herein showing the active site halide binding sites compared with those 
previously reported.17, 18 Active site views from the structures of the OXA-10:avibactam 
complex with bound (A) bromide ions (PDB 5MNU), and (B) iodide ions (PDB 5MOZ; refined 
occupancies of 70 % and 30 % for IA and IB, respectively). Active site views for reported 
structures of OXA:halide ion complexes showing (C) V117T OXA-10 with a bound chloride ion 
(PDB 2WGV),17 (D) OXA-163 with a bound iodide ion (PDB 4S2M),18 and (E) OXA-10 with a 
bound water molecule (W; PDB 1FOF).19 Paetzel et al. observed that the Lys-70 associated 
water molecule (panel E) may be replaced with a chloride ion.19
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Figure S12. Effects of halide ions on OXA-10 catalysis. The impact of (A) fluoride, (B) 
chloride, (C) bromide, and (D) iodide ions on OXA-10 catalysed hydrolysis of ampicillin as 
observed by 1H-NMR (700 MHz). Reaction mixtures consisted of 75 nM enzyme, 50 mM or 500 
mM of the appropriate sodium halide and 10 mM ampicillin in 50 mM Tris-d11, pH 7.5, 10 % 
D2O.
S20
Figure S13. Mode of OXA-23 inhibition by iodide ions. Kinetic characterisation of the 
inhibition of OXA-23 by iodide ions, showing (A) IC50 determination, (B) Dixon plot, and (C) 
Cornish-Bowden plot. Replicates of the (D) Dixon plot and the (E) Cornish-Bowden plot are also 
shown. GraphPad Prism 5 (GraphPad Software) was used for IC50 determination.
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Figure S14. Decarbamylation of OXA-10 by sodium bromide. 13C-NMR spectra (600 MHz) 
showing the impact of 0, 50, and 500 mM sodium bromide on 800 µM 13C-labeled (A) OXA-10 
and (B) OXA-23, in the presence of 15 mM avibactam, 50 mM sodium phosphate, pH 7.5, 10 
mM NaH13CO3, and 10 % D2O.
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Figure S15. Impact of alkali metals on OXA carbamylation. (A) 13C-NMR spectrum (600 
MHz) for 13C-labelled OXA-23 (800 M; in 50 mM sodium phosphate, pH 7.5, 10 mM 
NaH13CO3, 10 % D2O). 13C-NMR spectra (600 MHz) for OXA-23 (800 M; in 25 mM HEPES, 
pH 7.5, 100 mM NaCl, 10 % D2O) with (B) no added salts, (C) 200 mM sodium phosphate, pH 
7.4, and (D) 200 mM potassium phosphate, pH 7.4.
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Figure S16. Results from QM/MM geometry optimization calculations on the OXA-10 
active site. Overlays of active site conformations for systems with neutral Nε Lys-70 (purple) 
and protonated Nε (blue) Lys-70 compared to the refined crystal structure (white). The QM 
region comprised Ser-67 reacted with avibactam, Lys-70, Ser-115, Trp-154 and up to three water 
molecules. Calculations with a neutral Lys-70 Nε amino group resulted in optimized ion-Lys-70 
distances consistently closer to those observed in crystal structures than with a protonated Lys-70 
(Table S5). Water molecules are indicated in red.
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Table S1. Kinetic characterization of OXA substrates using nitrocefin and FC5 as substrates.20
kcat (s-1) Vmax (M s-1) Km (M) kcat/Km (s-1 M-1)
OXA-23 
(no NaHCO3)
Nitrocefin 759 1.518  0.118 15.21  4.89 4.99 x 107
FC5 78 0.975  0.062 25.04  2.63 3.12 x 106
OXA-23 
(50 mM NaHCO3)
Nitrocefin 2793 5.586  0.318 49.99  9.38 5.59 x 107
FC5 79.39 0.992  0.107 22.3  3.41 3.56 x 106
OXA-48
(no NaHCO3)
Nitrocefin 1919 3.838  0.275 27.06  7.35 7.09 x 107
FC5 76.58 0.957  0.067 31.5  3.42 2.43 x 106
OXA-48
(50 mM NaHCO3)
Nitrocefin 4806 9.612  0.412 61.64  8.27 7.80 x 107
FC5 108.6 1.358  0.199 48.13  8.52 2.26 x 106
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Table S2. Data collection and refinement statistics
Structure OXA-10−EPE OXA-10−AVI_I OXA-10−AVI_BR OXA-10−AVI_CO
PDB ID 5MMY 5MOZ 5MNU 5MOX
Radiation Source Diamond I04 Diamond I04 Diamond I04 Diamond I04
Resolution Range (Å) 51.09  - 1.88 
(1.94  - 1.88)‡
53.77  - 1.34 
(1.38  - 1.34)
63.61  - 1.56 
(1.61  - 1.56) ‡
76.76  - 1.41
(1.46  - 1.41)
Space group P 21 21 21 P 21 21 21 P 21 21 21 P 21 21 21
Unit cell dimensions
a,b,c (Å) 48.77 102.12 127.4 48.84 101.65 126.72 48.77 101.42 127.21 48.75 96.63 126.36
α,β,γ (°) 90 90 90 90 90 90 90 90 90 90 90 90
No. of molecules/ASU 2 2 2 2
No. of unique reflections 52491 (5120)‡ 141885 (13962) 90636 (8954) ‡ 115719 (11449) ‡
Completeness (%) 100 (99.7)‡ 99.9 (99.2) ‡ 100 (100)‡ 100 (100)‡
Redundancy 12.9(11.5)‡ 12.8(12.1)‡ 13.0(13.0)‡ 12.9(12.6)‡
Rmerge 0.172(2.092)‡ 0.103(2.828)‡ 0.162(2.789)‡ 0.184(3.083)‡
Mean I/σ(I) 11.8(3.2)‡ 11.2(1.1)‡ 9(1.3)‡ 9.5(1.2)‡
CC1/2 0.99(0.76) 0.99(0.46) 0.99(0.53) 0.99(0.51)
Wilson B value (Å2) 18.08 15.21 17.86 12.22
Refinement
Rfactor 0.1778 (0.2963)‡ 0.1663 (0.3733) ‡ 0.1850 (0.3691) ‡ 0.1573 (0.3254) ‡
Rfree 0.1979 (0.2604)‡ 0.1839 (0.3819) ‡ 0.2081 (0.3593) ‡ 0.1897 (0.3599) ‡
R.m.s.d.
Bond length (Å) 0.006 0.012 0.004 0.008
Bond angle (°) 0.766 1.191 0.748 1.156
Total no. of atoms 4205 4551 4504 4621
Protein 3847 3917 3889 3921
Ligand/ion 56 98 101 69
Water 302 536 514 631
Ramachandran allowed (%) 97 97 98 98
Ramachandran outliers (%) 3.2 2.6 2 2.2
Rotamer outliers (%) 0 0 0 0.2
<Bfactor> (Å2)
Protein 31.70 26.37 30.19 16.87
Ligand/ion 41.19 32.13 38.80 24.92
Water 36.03 35.90 36.78 32.10
Rmerge is the unweighted R-value on I between merged reflections.
Rfactor = Σhkl | |Fobs (hkl)| - |Fcalc (hkl)| | / Σhkl |Fobs (hkl)| for the working set of reflections.
‡ outermost shell.
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Table S3. Details of the systems studied included in the analyses on the protonation state of Lys-
70, the number of atoms in the QM region, the total number of atoms in the system, and the 
active site atom or molecule unique to each system.
Chain Lys-70 protonation state QM atoms System Size Particle
A – Br- 74 48194 Br-
B – Br- 77 48080 Br-
A – CO2 80 48192 CO2
B – CO2 80 48252 Na+
A – I- 74 48135 I-
B – I-
Neutral
74 48130 I-
A – Br- 75 48195 Br-
B – Br- 78 48081 Br-
A – CO2 81 48193 CO2
B – Na+ 81 48253 Na+
A – I- 75 48136 I-
B – I-
Protonated
75 48131 I-
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Table S4. Description of QM region including total charge for each system considered with 
protonated Lys-70 (-NH3+; top two tables) and neutral Lys-70 (-NH2; bottom two tables).
Protonated:
Chain A Br Charge CO2 Charge I Charge
Ser-67 -1 Ser-67 -1 Ser-67 -1
Lys-70 +1 Lys-70 +1 Lys-70 +1
Ser-115 0 Ser-115 0 Ser-115 0
Trp-154 0 Trp-154 0 Trp-154 0
Br- -1 CO2 0 I- -1
QM Region
Wat32 0 Wat31 0 Wat27 0
Total charge -1 0 -1
Chain B Br Charge Na Charge I Charge
Ser-67 -1 Ser-67 -1 Ser-67 -1
Lys-70 +1 Lys-70 +1 Lys-70 1
Ser-115 0 Ser-115 0 Ser-115 0
Trp-154 0 Trp-154 0 Trp-154 0
Br- -1 Na+ +1 I- -1
Wat202 0 Wat618 0 Wat348 0
Wat492 0 Wat176 0
QM Region
Wat56 0
Total charge -1 1 -1
Neutral:
Chain A Br- Charge CO2 Charge I- Charge
Ser-67 -1 Ser-67 -1 Ser-67 -1
Lys-70 0 Lys-70 0 Lys-70 0
Ser-115 0 Ser-115 0 Ser-115 0
Trp-154 0 Trp-154 0 Trp-154 0
Br- -1 CO2 0 I- -1
QM Region
Wat32 0 Wat31 0 Wat27 0
Total charge -2 -1 -2
Chain B Br- Charge Na+ Charge I- Charge
Ser-67 -1 Ser-67 -1 Ser-67 -1
Lys-70 0 Lys-70 0 Lys-70 0
Ser-115 0 Ser-115 0 Ser-115 0
Trp-154 0 Trp-154 0 Trp-154 0
Br- -1 Na+ +1 I- -1
Wat202 0 Wat618 0 Wat348 0
Wat492 0 Wat176 0 Wat302 0
QM Region
Wat56 0
Total charge -2 0 -2
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Table S5. Comparison of the Lys-70-ion distances as observed in the crystalline state (PDB 
5MNU, 5MOX, 5MOZ) and from the QM/MM calculations. The distances were measured from 
the Lys-70 Nε atom (top table) and from the Lys-70 C atom (bottom table).
Lys-70 Nε distances:
Chain
Lys-70 
protonation 
state Particle
Crystallographic Lys-
70-ion distance
(Å)
QM/MM Optimized
Lys-70-ion distance
(Å)
Deviation
(Å)
A – Br- Br- 3.2 3.4 0.2
B – Br- Br- 4.9 4.9 0.0
A – CO2 CO2 2.9 2.8 -0.1
B – Na+ Na+ 2.9 2.4 -0.5
A – I- I- 3.4 3.5 0.1
B – I-
Neutral
I- 4.7 3.8 -0.9
A – Br- Br- 3.2 3.1 -0.1
B – Br- Br- 4.9 4.5 -0.4
A – CO2 CO2 2.9 3.3 0.4
B – Na+ Na+ 2.9 4.4 1.5
A – I- I- 3.4 3.3 -0.1
B – I-
Protonated
I- 4.7 3.3 -0.1
Lys-70 C distances:
Chain
Lys-70 
protonation 
state Particle
Crystallographic Lys-
70-ion distance
(Å)
QM/MM Optimized
Lys-70-ion distance
(Å)
Deviation
(Å)
A – Br- Br- 5.4 5.9 0.4
B – Br- Br- 7.6 7.6 0.0
A – CO2 CO2 5.4 5.3 -0.1
B – Na+ Na+ 5.2 4.9 -0.3
A – I- I- 5.6 6.4 0.8
B – I-
Neutral
I- 7.6 7.6 0.0
A – Br- Br- 5.4 5.7 0.3
B – Br- Br- 7.6 7.6 0.0
A – CO2 CO2 5.4 5.3 -0.1
B – Na+ Na+ 5.2 6.4 1.2
A – I- I- 5.6 6.4 0.8
B – I-
Protonated
I- 7.5 6.2 0.7
S29
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